Use of tricyclic antidepressants and risk of glioma: a nationwide case-control study
- PMID: 27115466
- PMCID: PMC4891498
- DOI: 10.1038/bjc.2016.109
Use of tricyclic antidepressants and risk of glioma: a nationwide case-control study
Abstract
Background: A protective effect of tricyclic antidepressants (TCAs) against gliomas has been suggested by a small number of studies. We investigated this putative association in a nationwide setting.
Methods: Using a case-control design, we identified all patients with histologically verified glioma (cases) in Denmark between 2000 and 2012 and matched these 1 : 20 to population controls. Conditional logistic regression was used to estimate adjusted odds ratios (ORs) for glioma associated with long-term (⩾3 years) use of TCAs. Similar analyses were performed for selective serotonin reuptake inhibitors (SSRIs).
Results: We identified 3767 glioma cases and 75 340 population controls. Long-term use of TCAs was inversely associated with risk of glioma (OR 0.72, 95% CI: 0.41-1.25). Long-term SSRI use was not associated with glioma risk (OR 0.93, 95% CI: 0.75-1.16).
Conclusions: Our study indicated that long-term use of TCAs may be associated with a reduced risk of glioma, however, the statistical precision was limited. A similar pattern was not observed for use of SSRIs.
Similar articles
-
Use of statins and risk of glioma: a nationwide case-control study in Denmark.Br J Cancer. 2013 Feb 19;108(3):715-20. doi: 10.1038/bjc.2012.536. Epub 2013 Jan 15. Br J Cancer. 2013. PMID: 23322196 Free PMC article.
-
Use of antidepressants and endometrial-cancer risk: a nationwide nested case-control study.Int J Epidemiol. 2022 Jun 13;51(3):799-806. doi: 10.1093/ije/dyab200. Int J Epidemiol. 2022. PMID: 34550389
-
Does the use of SSRIs reduce medical care utilization and expenditures?J Ment Health Policy Econ. 2005 Sep;8(3):119-29. J Ment Health Policy Econ. 2005. PMID: 16278500
-
Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.Clin Ther. 2014 Jul 1;36(7):1087-1095.e4. doi: 10.1016/j.clinthera.2014.06.001. Epub 2014 Jul 3. Clin Ther. 2014. PMID: 24998011 Review.
-
Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.J Affect Disord. 2013 Jan 10;144(1-2):7-15. doi: 10.1016/j.jad.2012.06.007. Epub 2012 Sep 7. J Affect Disord. 2013. PMID: 22963896 Review.
Cited by
-
Repurposing autophagy regulators in brain tumors.Int J Cancer. 2022 Jul 15;151(2):167-180. doi: 10.1002/ijc.33965. Epub 2022 Mar 4. Int J Cancer. 2022. PMID: 35179776 Free PMC article. Review.
-
Antidepressant drugs and risk of developing glioma: a national registry-based case-control study and a meta-analysis.Am J Epidemiol. 2024 Nov 4;193(11):1592-1599. doi: 10.1093/aje/kwae100. Am J Epidemiol. 2024. PMID: 38825331 Free PMC article.
-
Tumor microenvironment in glioblastoma: Current and emerging concepts.Neurooncol Adv. 2023 Feb 23;5(1):vdad009. doi: 10.1093/noajnl/vdad009. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 36968288 Free PMC article. Review.
-
Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-κB signalling participate in anti-glioblastoma of imipramine.J Cell Mol Med. 2020 Apr;24(7):3982-4000. doi: 10.1111/jcmm.15022. Epub 2020 Mar 9. J Cell Mol Med. 2020. PMID: 32149465 Free PMC article.
-
Drug Repositioning in Glioblastoma: A Pathway Perspective.Front Pharmacol. 2018 Mar 16;9:218. doi: 10.3389/fphar.2018.00218. eCollection 2018. Front Pharmacol. 2018. PMID: 29615902 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical